NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biopharmaceutical’

4 August 2016

3i Group nabs 3.3x return though Quintiles sale

dna-163466_1280 UK-headquartered 3i Group has scored a 3.3-times return through its investment in Quintiles, having sold its remaining shares in the business.

17 March 2016

Frazier Healthcare teams with Takeda to launch Japanese bio business

test-tubes-904546_1920 Specialist US private equity firm Frazier Healthcare Partners has teamed with Takeda Pharmaceutical to form a Japan-based biopharma business called Outpost Medicine.

8 September 2015

Ysios Capital leads €36.6m Series C for drug developer Sanifit

pills-530372_1280 Spanish early-stage investment firm Ysios Capital has led a €36.6m Series C investment round for clinical-stage biopharma business Laboratoris Sanifit.

13 April 2015

TVM Capital reveals Hong Kong expansion amid China biopharma fund close

life science test tube_sq Venture capital investor TVM Capital Life Science has hit a $50m first close for its first biopharma fund exclusively focused on expanding Western businesses to the Chinese market.

4 March 2015

OrbiMed leads weighty $30m round in biopharmaceutical company Tricida

download (65) Venture capital firm OrbiMed has led a $30m Series B financing round in San Francisco-based biopharmaceutical company Tricida.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

23 February 2015

VC-backed Heptares Therapeutics sold to Japanese trade partner for $400m

sold-sale-exit-deal UK biopharmaceutical Heptares Therapeutics, whose backers have included MVM Life Science Partners, Novartis Venture Fund and Takeda Ventures, has been sold to Tokyo-listed pharma company Sosei Group Corporation.

28 January 2015

VC-backed Zosano Pharma launches IPO

Pharmedium drugs Venture capital-backed biopharmaceutical company Zosano Pharma has launched for an Intial public offering, pricing its 4.5 million shares at $11 per share.

2 January 2015

Aperture reels in nearly $50m for third health-care fund

health healthcare drugs pills medication medical New York-based investor Aperture Venture Partners has reeled in nearly half of its $100m target for its third fund health-care fund, AltAssets can reveal.

22 October 2014

Brandon Point, Woodford in Series D round for biopharmaceutical

fungus-3-1411424-m UK fund manager Woodford Investment Management and Brandon Point Industries have provided $60m Series D financing for antifungal research company Viamet Pharmaceuticals Holdings.

Page 1 of 612345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016